No matches
Rhinology

CRSwNP MoD Video

Prof. Wytske Fokkens examines what is known and what else should be explored to understand the mechanisms of anosmia in patients with CRSwNP.
Wytske Fokkens
MD, PhD
Wytske Fokkens

Related resources

Partnering With Patients for Clinical Decision-Making in CRSwNP

Partnering With Patients for Clinical Decision-Making in CRSwNP

expert video
Connecting Type 2 Inflammation to CRSwNP

Connecting Type 2 Inflammation to CRSwNP

expert video
Loss of Smell is a Key Symptom of CRSwNP

Loss of Smell is a Key Symptom of CRSwNP

interactivity
Partnering With Patients: Scores That Matter in CRSwNP

Partnering With Patients: Scores That Matter in CRSwNP

interactivity
Compounded Burden of Co-existing Type 2 Airway Diseases

Compounded Burden of Co-existing Type 2 Airway Diseases

expert video
Spotlight on Type 2 Inflammation in the Upper and Lower Airways

Spotlight on Type 2 Inflammation in the Upper and Lower Airways

expert video
Type 2 Inflammation: Links With Severe Uncontrolled CRSwNP

Type 2 Inflammation: Links With Severe Uncontrolled CRSwNP

expert video
CRSwNP Interactive Patient Case Tool

CRSwNP Interactive Patient Case Tool

interactivity
The Burden in Patients with CRSwNP and Coexisting Asthma

The Burden in Patients with CRSwNP and Coexisting Asthma

expert video
Assessment of Smell Loss in CRSwNP Interactive Infographic

Assessment of Smell Loss in CRSwNP Interactive Infographic

interactivity
AANP 2025 | Atopic Diseases & a Case-Based Panel of Nurse Practitioners

AANP 2025 | Atopic Diseases & a Case-Based Panel of Nurse Practitioners

videoanimation
ADVENT On Air | Back Again: Predicting Recurrence in Chronic Rhinosinusitis with Nasal Polyps

ADVENT On Air | Back Again: Predicting Recurrence in Chronic Rhinosinusitis with Nasal Polyps

Podcast
CRSwNP Triathlon: An Interactive Learning Experience

CRSwNP Triathlon: An Interactive Learning Experience

interactivity

Learning objectives

  • Learn about the currently proposed mechanisms of anosmia in patients with CRSwNP
  • Understand the remaining knowledge gaps and consider the need to increase the understanding of anosmia in CRSwNP
Tags
loss of smelltype 2 inflammationendotype
MAT-US-2408292 v1.0 - P Exp Date: 08/23/2026

About this expert

Rhinology

Wytske Fokkens

MD, PhD

Professor in the Department of Otorhinolaryngology | Academic Medical Center, Amsterdam, Netherlands; Director | European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA)

See author’s profile
Wytske Fokkens

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v4.0 – P Expiration Date: 10/16/2027

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region